Rucaparib (Compound)

Synonyms:RUCAPARIB, 283173-50-2, Rubraca, AG-14447, Rucaparib free base, Rucaparib (free base), Kinome_3180, 8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one, 8237F3U7EH, 283173-50-2 (free base), 8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON, 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one, 8-FLUORO-2-(4-((METHYLAMINO)METHYL)PHENYL)-4,5-DIHYDRO-1H-AZEPINO[5,4,3-CD]INDOL-6(3H)-ONE, 8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one, 6H-Azepino(5,4,3-cd)indol-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-, 6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-, C19H18FN3O, Rucaparib [INN], Rucaparib [USAN:INN], PF 01367338, UNII-8237F3U7EH, 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, RPB, RUCAPARIB [MI], Rucaparib (USAN/INN), RUCAPARIB [USAN], RUCAPARIB [WHO-DD], Rucaparib(AG-014447), 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-, SCHEMBL844585, GTPL7736, CHEMBL1173055, CHEBI:94311, DTXSID10182563, CHEBI:134689, BCP07633, EX-A2700, BDBM50446130, HY-10617A, NSC756644, s4948, AKOS015898427, AG14447, DB12332, NSC-756644, SB16538, NCGC00263173-01, NCGC00263173-03, NCGC00263173-09, NCGC00263173-13, 6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one, AC-24390, AS-74779, FT-0696622, A14182, C74459, D10079, Rucaparib; AG 014699; PF-01367338, A856084, Q7376558, BRD-K88560311-011-01-4, 6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.0^{4,13]trideca-1,4,6,8(13)-tetraen-9-one, 6-fluoro-2-{4-[(methylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0?,(1)(3)]trideca-1,4,6,8(13)-tetraen-9-one, 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl], 8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one

Pubchem:PUBCHEM:9931954

Id:a6ad2293-417b-52b7-8cf0-691c5b36685b

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Rucaparib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Rucaparib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Rucaparib.

Results found

Linked to

	Label	Description
	BRD-K88560311-011-06-3 Substance (Entity type)	A Substance
	rucaparib (71265ea8-f40c-431b-bb0f-baec3512ceed) Collection (Entity type)	Metadatata for rucaparib
	DCSTRUCT ID 05203 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05203; PubChem_CID:9931954, FILE=drugcentral_drug_05203.json)
	Rucaparib negatively regulates APOD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rucaparib positively regulates RRS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Veliparib in similarity relationship with Rucaparib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rucaparib positively regulates SESN1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	seliciclib in similarity relationship with Rucaparib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rucaparib positively regulates ALDH18A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Rucaparib positively regulates NOP16 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS